Hexapradol

Hexapradol
Clinical data
Other names	α-Butyl-β-hydroxy-β-phenylamphetamine; α-Pentyl-β-hydroxy-β-phenyl-2-phenethylamine; β-Phenyl-2-phenylheptanolamine
ATC code	None;
Identifiers
	IUPAC name 2-amino-1,1-diphenyl-1-heptanol;
CAS Number	15599-37-8;
PubChem CID	219120;
ChemSpider	189933;
UNII	I71G9YBD89;
ChEMBL	ChEMBL2107201;
CompTox Dashboard (EPA)	DTXSID60864605 ;
Chemical and physical data
Formula	C19H25NO
Molar mass	283.415 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES OC(c1ccccc1)(c2ccccc2)C(N)CCCCC;
	InChI InChI=1S/C19H25NO/c1-2-3-6-15-18(20)19(21,16-11-7-4-8-12-16)17-13-9-5-10-14-17/h4-5,7-14,18,21H,2-3,6,15,20H2,1H3; Key:ZVRZJTRBWTVKOJ-UHFFFAOYSA-N;

Hexapradol (INN) is a psychostimulant drug which was never marketed.¹

It also had cytoprotective/antiulcer properties.²

Synthesis

Synthesis methods are described.³

Ganellin CR, Triggle DJ (21 November 1996). Dictionary of Pharmacological Agents. Vol. 2. CRC Press. p. 1023. ISBN 978-0-412-46630-4. Retrieved 26 April 2012.
Scuri R, Mondani G, Fantini PL, Dàlla Valle V, Valsecchi B (September 1984). "Hexaprazol: a new antiulcer drug with a cytoprotective action". Bollettino Chimico Farmaceutico. 123 (9): 425–38. PMID 6529496.
GB 805511, "1,1-diaryl-2-aminoalkanols", published 1958-12-10, assigned to Mead Johnson & Co.